Third of Americans say they are unlikely to get COVID-19 vaccine
A new study by the University of California, Davis has found that a third of Americans are either unlikely or hesitant to get a COVID-19 vaccine when it becomes available.
Johnson & Johnson vaccine has 66% efficiency in one dose
New clinical trial data shows that the Johnson & Johnson vaccine is able to give 66% protection against COVID in one dose - with an 85% efficiency at the standard double-dose.
The EU authorises AstraZeneca COVID vaccine for use
European regulators have approved their third vaccine, AstraZeneca - which comes after a week of tense communications between the two parties.
Three ways to solve the logistical challenges of giving COVID vaccines
An anonymous Doctor explains their ideas for how the NHS could tackle the significant logistical challenges of giving COVID vaccines.
Novavax vaccine is 85.6% efficient against UK COVID mutation
Phase Three data from the UK trial shows that Novavax still works powerfully against the UK mutation, with a less intense impact on the South African mutation at 60%.
Engineers design model for using one ventilator on two patients
Engineers at the University of Bath have published a mathematical model that could help clinicians to safely ventilate two COVID patients on one ventilator.
Is this a vaccine war or the first post-Brexit war?
Right now, the rift between AstraZeneca and the European Commission continues to grow - but is it a vaccine war or the first post-Brexit war?
REACT study: UK scientists aren’t seeing a “sharp drop in infections”
New data from the REACT study finds that the rising infection rate has steadied a little, but there is no "sharp drop in infections" as in the first wave and the R is still high.
AstraZeneca CEO discusses the European Commission vaccine feud
AstraZeneca CEO Pascal Soriot spoke to Antonello Guerrera about the ongoing vaccine feud - with the Commission receiving 60% less than expected, raising tense questions about why.
Green paper explores challenges and opportunities of Europe’s ageing society
The European Commission has presented a green paper to launch a broad policy debate on the challenges and opportunities of Europe's ageing population.
Israel’s vaccine data suggests that Pfizer is performing at the expected 95%
New vaccine data from Israel suggests that the double-dose of Pfizer is performing at the expected rate of 95% efficiency - with the possibility that it is performing even better than that being further investigated.
People with high omega-3 blood levels are less likely to die from COVID-19
Researchers have found that people with higher omega-3 blood levels have a reduced risk of death from COVID-19.
Moderna vaccine works on South African COVID mutation
The company announced that their current vaccine can handle the South African COVID mutation - with plans to create an "additional booster dose" to see if they can create specific protections against emerging variants.
UK offers genomics expertise to find COVID-19 virus variants across the world
The UK will offer its world-leading genomics expertise to identify new variants of the COVID-19 virus to countries who do not have the resources to do so.
European Commission will get 60% less AstraZeneca vaccines
EU leaders are investigating why AstraZeneca are not following through with the pre-agreed number of vaccines for the Member States - taking a 60% cut to the expected amount.
Studies show promising results for new Oxford COVID-19 vaccine
Studies show that the new Oxford-produced RBD-SpyVLP COVID-19 vaccine produces a strong antibody response in mice and pigs.
Asian COVID patients are 1.5 times more likely to die
Data from Queen Mary University of London suggests that Asian COVID patients are 1.5 times as likely to die as white patients - with Black patients 1.3 times more likely to die.
Scientist warns UK not to rely on one dose of COVID vaccine
Professor Herb Sewell, expert in immunology, wrote that the UK Government should not rely on one dose of the vaccine - suggesting that the diluted vaccine could encourage mutations to evolve.
REACT study: There is “extreme pressure on healthcare services”
New data from the REACT study says that there have been more than 20 hospitals' worth of new patients since Christmas Eve, putting "extreme pressure" on the NHS.
COVID-19 spike proteins could evolve against immune responses
A new study suggests that COVID-19 spike proteins could evolve to disguise themselves from the human immune system.
